Gopal Natesan

Employment

• Institute of Pharmacy, Nirma University Director
  2023 - Present
• Mahsa University Professor in Pharmaceutical Chemistry
  2009 - 2023
• Balaji Institute of Pharmaceutical Sciences Professor and Principal
  2006 - 2009

Education

• Mahsa University MBA
  2021 - 2022
• Anglia Ruskin University Postgraduate Certificate in Learning and Teaching (Higher Education)
  2015 - 2016
• Jamia Hamdard Faculty of Pharmacy Doctor of Philosophy in Pharmaceutical Chemistry
  1997 - 2001
• JSS College of Pharmacy Master of Pharmacy (Pharmaceutical Chemistry)
  1994 - 1996
• JKK Natarajah College of Pharmacy and Research Institute Bachelor of Pharmacy
  1989 - 1993

Projects & Funding

Projects & funding information is unavailable.

Publications (83)

• Advancements in breast cancer therapy: Integrating AI tools for drug discovery and clinical trials
  Computers in Biology and Medicine 2025 DOI: 10.1016/j.compbiomed.2025.111067
  +Save
• Uncovering Necroptosis in Alzheimer’s Disease: A Systematic Review of Evidence Across Experimental Models
  Cellular and Molecular Neurobiology 2025 DOI: 10.1007/s10571-025-01601-w
  +Save
• Morpholine-Substituted Tetrahydroquinoline Derivatives as Potential mTOR Inhibitors: Synthesis, Computational Insights, and Cellular Analysis
  Cancers 2025 DOI: 10.3390/cancers17050759
  +Save
• Optimizing Dielectric Barrier Discharge Pencil Plasma Jet Treatment for Efficient Degradation of Organic Contaminants in Denim Industry Wastewater
  Plasma Chemistry and Plasma Processing 2025 DOI: 10.1007/s11090-025-10544-5
  +Save
• In Search of PI3K Inhibitors as Anticancer Agents: Molecular Modelling Through Virtual Screening, ADMET, and Molecular Dynamics Simulations
  ChemistrySelect 2025 DOI: 10.1002/slct.202500406
  +Save
• Investigations Through In Silico Molecular Modelling Against Falcipain‐2 in Search of Potent Anti‐Malarial Agents
  ChemistrySelect 2025 DOI: 10.1002/slct.202405449
  +Save
• Synthesis, Antimicrobial Evaluation, Molecular Docking and Dynamics Simulations of Novel 2,3‐Disubstituted Quinazolin‐4(3H)‐one Derivatives
  ChemistrySelect 2024 DOI: 10.1002/slct.202403009
  +Save
• A summary of the second MACR international scientific conference (2nd MSC)
  Oncologie 2023 DOI: 10.1515/oncologie-2023-0130
  +Save
• Antibacterial activity of newer Quinazolin-4(3H)-one derivatives
  International Conference on Drug Discovery and Translational Medicine 2018 (ICDDTM '18) “Seizing Opportunities and Addressing Challenges of Precision Medicine”, Putrajaya, Malaysia, 3 Dec - 5 Dec, 2018. 2019
  +Save
• Effect of Glutathione, Ascorbic Acid and Multivitamins on Sensitivity of Norfloxacin against Pseudomonas aeruginosa and Klebsiella pneumoniae
  Journal of Pure and Applied Microbiology 2019
  +Save